CRP and endothelial dysfunction: Two studies explored potential mechanisms linking CVD with CV outcomes, identifying elevated systemic inflammatory markers, such as C-reactive protein (CRP) and IL-6, and signs of endothelial dysfunction, including reduced flow-mediated dilation and increased arterial stiffness in patients with CVD.7